At what dose does Phenylpiracetam produce irritability?

Effects like irritability are typically reported at common doses and above. A common oral dose of Phenylpiracetam is 100–200 mg.

What other substances cause irritability?

Other substances documented to produce irritability include Oxycodone, Methamphetamine, 3,4-CTMP, Serotonin, Mirtazapine, and 35 more.

Irritability from Phenylpiracetam — Detailed Guide

Q: Does Phenylpiracetam cause irritability?

Yes. Irritability is a documented cognitive effect of Phenylpiracetam. Irritability is a sustained state of emotional reactivity in which the threshold for annoyance, frustration, and anger is significantly lowered — causing minor inconveniences, social interactions, or environmental stimuli that would normally be tolerated without difficulty to provoke disproportionate agitation or hostility.

Irritability from Phenylpiracetam

cognitiveStimulants, Nootropic

Irritability + Phenylpiracetam

Effect category

cognitive

Substance class

Stimulants, Nootropic

Chemical class

Racetams

Routes of administration

oral

Other effects from Phenylpiracetam

Other substances causing this effect

Irritability + Phenylpiracetam

Effect category

cognitive

Substance class

Stimulants, Nootropic

Chemical class

Racetams

Routes of administration

oral

Other Phenylpiracetam effects

Substances causing irritability

Phenylpiracetam is known to produce irritability, a cognitive effect. Irritability is a sustained state of emotional reactivity in which the threshold for annoyance, frustration, and anger is significantly lowered — causing minor inconveniences, social interactions, or environmental stimuli that would normally be tolerated without difficulty to provoke disproportionate agitation or hostility.

About Irritability

Irritability in the context of psychoactive substance use refers to a pervasive emotional state characterized by a markedly reduced tolerance for frustration, annoyance, and perceived inconvenience. The person becomes easily provoked by stimuli that would normally be handled with equanimity — a slightly too-loud noise, a minor disagreement, someone asking a question at the wrong moment, physical discomfort that would ordinarily be ignored. The internal experience is one of being perpetually on edge, with anger and frustration simmering just below the surface, ready to erupt at minimal provocation.

The manifestation of irritability ranges from internalized tension (clenching jaw, tightening muscles, seething silently) to externalized hostility (snapping at companions, making cutting remarks, slamming objects, or in severe cases, physical aggression). What distinguishes substance-induced irritability from ordinary bad mood is often its intensity and disproportionality — the person may recognize that their anger is out of proportion to the trigger but feel unable to modulate their response. Small things feel enormous. The ability to pause between stimulus and response, which normally prevents overreaction, is compromised.

Several pharmacological mechanisms can produce irritability. Serotonin depletion following heavy MDMA or stimulant use removes the neurochemical buffer that normally smooths emotional responses.GABA withdrawal (from alcohol, benzodiazepines, or GHB) produces a hyperexcitable nervous system that is physiologically primed for overreaction.Noradrenergic excess from stimulants or stimulant withdrawal creates a fight-or-flight bias that interprets neutral stimuli as threats.Sleep deprivation — a common consequence of stimulant use — dramatically reduces emotional regulation capacity.Nicotine withdrawal is one of the most reliably irritability-producing states known.

Irritability is most commonly associated with the comedown or withdrawal phases of stimulants (amphetamines, cocaine),alcohol withdrawal,benzodiazepine withdrawal,opioid withdrawal,nicotine withdrawal,MDMA aftereffects, andchronic cannabis use (particularly during tolerance breaks). It can also occur during the acute effects ofanabolic steroids, high doses ofcaffeine, and someantidepressants during dose adjustments.

Harm reduction note: Irritability during a comedown or withdrawal period is neurochemically driven and temporary — your brain is operating with depleted resources and an unbalanced neurochemistry, and your subjective experience of the world is being distorted toward threat and annoyance. If you recognize that you are in an irritable state: avoid situations likely to provoke conflict, let people around you know that you are feeling on edge (this creates understanding and reduces the likelihood of triggering interactions), and remember that this state will pass as your neurochemistry rebalances. If irritability becomes severe enough to involve thoughts of violence or actual aggressive behavior, remove yourself from the situation and seek support.

How Phenylpiracetam Produces This Effect

Pharmacodynamics Phenylpiracetam is a racetam and is described as a stimulant. Racetams have a variety of different pharmacological activities and have varying effects. For example, phenylpiracetam is a stimulant, piracetam is a nootropic, and levetiracetam is an anticonvulsant. The mechanisms of action of most racetams, with some exceptions, are unknown.

Phenylpiracetam is a racemic mixture. (R)-Phenylpiracetam is the most active enantiomer and is much more potent in stimulating locomotor activity than (S)-phenylpiracetam, which is ineffective. However, (S)-phenylpiracetam retains some activity in most pharmacological tests. On the other hand, in one animal test, the passive avoidance test, (S)-phenylpiracetam appeared to be antagonistic of (R)-phenylpiracetam.

Dopamine reuptake inhibitor Experiments performed on Sprague-Dawley rats in a European patent for using phenylpiracetam to treat sleep disorders showed an increase in extracellular dopamine levels after administration. The patent asserts discovery of phenylpiracetam's action as a dopamine reuptake inhibitor as its basis.

The peculiarity of this invention compared to former treatment approaches for treating sleep disorders is the so far unknown therapeutic efficacy of (R)-phenylpiracetam, which is presumably based at least in part on the newly identified activity of (R)-phenylpiracetam as the dopamine re-uptake inhibitor

Both enantiomers of phenylpiracetam, (R)-phenylpiracetam and (S)-phenylpiracetam, have been described in peer-reviewed research as dopamine transporter (DAT) inhibitors in rodents, confirming the patent claim. Their actions at the norepinephrine transporter (NET) vary: (R)-phenylpiracetam acts as a dual norepinephrine–dopamine reuptake inhibitor (NDRI), with 11-fold lower affinity for the NET than for the DAT, whereas the (S)-enantiomer is selective for the DAT. However, whereas (R)-phenylpiracetam stimulates locomotor activity, (S)-phenylpiracetam does not do so. This variation in effects has also been seen with other dopamine reuptake inhibitors.

Other atypical dopamine reuptake inhibitors include modafinil, mesocarb (Sydnocarb), and solriamfetol.

Other actions Phenylpiracetam binds to α4β2 nicotinic acetylcholine receptors in the mouse brain cortex with an IC50Tooltip half-maximal inhibitory concentration of 5.86μM.

Racetams generally, but including phenylpiracetam, have been described as AMPA receptor potentiators.

Animal studies Research on animals has indicated that phenylpiracetam may have antiamnesic, antidepressant, anxiolytic, and anticonvulsant effects. Additional clinical research is necessary to determine whether these effects extend to humans.

Phenylpiracetam has been shown to reverse the sedative or depressant effects of the benzodiazepine diazepam, increases operant behavior, inhibits post-rotational nystagmus, prevents retrograde amnesia, and has anticonvulsant properties in animal models.

In Wistar rats with gravitational cerebral ischemia, phenylpiracetam reduced the extent of neuralgic deficiency manifestations, retained the locomotor, research, and memory functions, increased the survival rate, and lead to the favoring of local cerebral flow restoration upon the occlusion of carotid arteries to a greater extent than did piracetam.

In tests against a control, Sprague-Dawley rats given free access to less-preferred rat chow and trained to operate a lever repeatedly to obtain preferred rat chow performed additional work when given methylphenidate, dextroamphetamine, and phenylpiracetam. Rats administered 100mg/kg phenylpiracetam performed, on average, 375% more work than rats given placebo, and consumed little non-preferred rat chow. In comparison, rats administered 1mg/kg dextroamphetamine or 10mg/kg methylphenidate performed, on average, 150% and 170% more work respectively, and consumed half as much non-preferred rat chow.

Present data show that (R)-phenylpiracetam increases motivation, i.e., the work load, which animals are willing to perform to obtain more rewarding food. At the same time consumption of freely available normal food does not increase. Generally this indicates that (R)-phenylpiracetam increase motivation [...] The effect of (R)-phenylpiracetam is much stronger than that of methylphenidate and amphetamine.

Pharmacokinetics The pharmacokinetics of phenylpiracetam in humans are unpublished. In any case, the drug is described as having an oral bioavailability of approximately 100%, as having an onset of action of less than 1hour, as not being metabolized, as being excreted unchanged about 40% in urine and 60% in bile and sweat, and as having an elimination half-life of 3 to 5hours. In rodents, its absorption occurs within 1hour with oral administration or intramuscular injection and its elimination half-life is 2.5 to 3hours.

Phenylpiracetam can be administered via oral. The route of administration can influence both the onset and intensity of irritability.

Irritability from Phenylpiracetam

Irritability + Phenylpiracetam

Irritability + Phenylpiracetam

About Irritability

How Phenylpiracetam Produces This Effect

Dosage Context

oral

Other Substances That Cause Irritability (40)

Antidepressant, Nootropic

Deliriant

Deliriant, Depressant, Antidepressants

Depressant

Entactogen

Entactogen, Stimulants

Neurotransmitter

Nootropic

Oneirogen

Opioids

Psychedelic

Stimulants

Stimulants, Opioids

See Also

Frequently Asked Questions

Irritability from Phenylpiracetam

Irritability + Phenylpiracetam

Irritability + Phenylpiracetam

About Irritability

How Phenylpiracetam Produces This Effect

Dosage Context

oral

Other Effects from Phenylpiracetam (28)

Other Substances That Cause Irritability (40)

Antidepressant, Nootropic

Deliriant

Deliriant, Depressant, Antidepressants

Depressant

Entactogen

Entactogen, Stimulants

Neurotransmitter

Nootropic

Oneirogen

Opioids

Psychedelic

Stimulants

Stimulants, Opioids

See Also

Frequently Asked Questions